APO Research
Talk to an analyst

APO RESEARCH · REPORT

POC HbA1C Testing

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

HbA1c is your average blood glucose (sugar) levels for the last two to three months.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

In this report, we mainly study the devices for POC HbA1C Testing without services.

Selected research

Market Analysis & Forecast

Global POC HbA1C Testing Market Analysis and Forecast 2026-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchPOC HbA1C Testing Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal POC HbA1C Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal POC HbA1C Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal POC HbA1C Testing Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal POC HbA1C Testing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

HbA1c is your average blood glucose (sugar) levels for the last two to three months.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

Read the full market overview

In this report, we mainly study the devices for POC HbA1C Testing without services.

The major players in global POC HbA1C Testing market include Abbott, Siemens, Roche, etc. The top 3 players occupy about 80% shares of the global market. North America and Europe are main markets, they occupy about 75% of the global market. Immunoassay is the main type, with a share about 50%. Hospital & Clinics is the main application, which holds a share about 60%.

Report Includes

This report presents an overview of global market for POC HbA1C Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of POC HbA1C Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for POC HbA1C Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the POC HbA1C Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global POC HbA1C Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for POC HbA1C Testing revenue, projected growth trends, production technology, application and end-user industry.

POC HbA1C Testing Segment by Company

Abbott

Siemens

Roche

Bio-Rad

GREEN CROSS MEDIS

Trinity Biotech

HUMAN Diagnostics

Sinocare (PTS Diagnostics)

Erba Diagnostics

EKF Diagnostics

OSANG Healthcare

SD Biosensor

POC HbA1C Testing Segment by Type

Immunoassay

Boronate Affinity

Others

POC HbA1C Testing Segment by Application

Hospital and Clinics

Diagnostic Laboratories

Others

POC HbA1C Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global POC HbA1C Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of POC HbA1C Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of POC HbA1C Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of POC HbA1C Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of POC HbA1C Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, POC HbA1C Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global POC HbA1C Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immunoassay Major Player Table 3. Boronate Affinity Major Player Table 4. Others Major Player Table 5. Global POC HbA1C Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital and Clinics Major Player Table 7. Diagnostic Laboratories Major Player Table 8. Others Major Player Table 9. POC HbA1C Testing Industry Trends Table 10. POC HbA1C Testing Industry Drivers Table 11. POC HbA1C Testing Industry Opportunities and Challenges Table 12. POC HbA1C Testing Industry Restraints Table 13. Global POC HbA1C Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global POC HbA1C Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global POC HbA1C Testing Market Share by Region (2021-2026) Table 16. Global POC HbA1C Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global POC HbA1C Testing Market Share by Region (2027-2032) Table 18. Global POC HbA1C Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global POC HbA1C Testing Revenue Market Share by Players (2021-2026) Table 20. Global POC HbA1C Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global POC HbA1C Testing Key Players Headquarters & Area Served Table 22. Global POC HbA1C Testing Players, Product Type & Application Table 23. Global POC HbA1C Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global POC HbA1C Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global POC HbA1C Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global POC HbA1C Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global POC HbA1C Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global POC HbA1C Testing Revenue Market Share by Type (2021-2026) Table 30. Global POC HbA1C Testing Revenue Market Share by Type (2027-2032) Table 31. Global POC HbA1C Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global POC HbA1C Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global POC HbA1C Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global POC HbA1C Testing Revenue Market Share by Application (2021-2026) Table 35. Global POC HbA1C Testing Revenue Market Share by Application (2027-2032) Table 36. Abbott Company Information Table 37. Abbott Business Overview Table 38. Abbott POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Abbott POC HbA1C Testing Product Portfolio Table 40. Abbott Recent Development Table 41. Siemens Company Information Table 42. Siemens Business Overview Table 43. Siemens POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Siemens POC HbA1C Testing Product Portfolio Table 45. Siemens Recent Development Table 46. Roche Company Information Table 47. Roche Business Overview Table 48. Roche POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Roche POC HbA1C Testing Product Portfolio Table 50. Roche Recent Development Table 51. Bio-Rad Company Information Table 52. Bio-Rad Business Overview Table 53. Bio-Rad POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bio-Rad POC HbA1C Testing Product Portfolio Table 55. Bio-Rad Recent Development Table 56. GREEN CROSS MEDIS Company Information Table 57. GREEN CROSS MEDIS Business Overview Table 58. GREEN CROSS MEDIS POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. GREEN CROSS MEDIS POC HbA1C Testing Product Portfolio Table 60. GREEN CROSS MEDIS Recent Development Table 61. Trinity Biotech Company Information Table 62. Trinity Biotech Business Overview Table 63. Trinity Biotech POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Trinity Biotech POC HbA1C Testing Product Portfolio Table 65. Trinity Biotech Recent Development Table 66. HUMAN Diagnostics Company Information Table 67. HUMAN Diagnostics Business Overview Table 68. HUMAN Diagnostics POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. HUMAN Diagnostics POC HbA1C Testing Product Portfolio Table 70. HUMAN Diagnostics Recent Development Table 71. Sinocare (PTS Diagnostics) Company Information Table 72. Sinocare (PTS Diagnostics) Business Overview Table 73. Sinocare (PTS Diagnostics) POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Sinocare (PTS Diagnostics) POC HbA1C Testing Product Portfolio Table 75. Sinocare (PTS Diagnostics) Recent Development Table 76. Erba Diagnostics Company Information Table 77. Erba Diagnostics Business Overview Table 78. Erba Diagnostics POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Erba Diagnostics POC HbA1C Testing Product Portfolio Table 80. Erba Diagnostics Recent Development Table 81. EKF Diagnostics Company Information Table 82. EKF Diagnostics Business Overview Table 83. EKF Diagnostics POC HbA1C Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. EKF Diagnostics POC HbA1C Testing Product Portfolio Table 85. EKF Diagnostics Recent Development Table 86. OSANG Healthcare Company Information Table 87. OSANG Healthcare Business Overview Table 88. OSANG Healthcare POC HbA1C Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. OSANG Healthcare POC HbA1C Testing Product Portfolio Table 90. OSANG Healthcare Recent Development Table 91. SD Biosensor Company Information Table 92. SD Biosensor Business Overview Table 93. SD Biosensor POC HbA1C Testing Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. SD Biosensor POC HbA1C Testing Product Portfolio Table 95. SD Biosensor Recent Development Table 96. North America POC HbA1C Testing Revenue by Type (2021-2026) & (US$ Million) Table 97. North America POC HbA1C Testing Revenue by Type (2027-2032) & (US$ Million) Table 98. North America POC HbA1C Testing Revenue by Application (2021-2026) & (US$ Million) Table 99. North America POC HbA1C Testing Revenue by Application (2027-2032) & (US$ Million) Table 100. North America POC HbA1C Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America POC HbA1C Testing Revenue by Country (2021-2026) & (US$ Million) Table 102. North America POC HbA1C Testing Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe POC HbA1C Testing Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe POC HbA1C Testing Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe POC HbA1C Testing Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe POC HbA1C Testing Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe POC HbA1C Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe POC HbA1C Testing Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe POC HbA1C Testing Revenue by Country (US$ Million) & (2027-2032) Table 110. China POC HbA1C Testing Revenue by Type (2021-2026) & (US$ Million) Table 111. China POC HbA1C Testing Revenue by Type (2027-2032) & (US$ Million) Table 112. China POC HbA1C Testing Revenue by Application (2021-2026) & (US$ Million) Table 113. China POC HbA1C Testing Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia POC HbA1C Testing Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia POC HbA1C Testing Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia POC HbA1C Testing Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia POC HbA1C Testing Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia POC HbA1C Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia POC HbA1C Testing Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia POC HbA1C Testing Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA POC HbA1C Testing Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA POC HbA1C Testing Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA POC HbA1C Testing Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA POC HbA1C Testing Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA POC HbA1C Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA POC HbA1C Testing Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA POC HbA1C Testing Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. POC HbA1C Testing Image Figure 2. Global POC HbA1C Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global POC HbA1C Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immunoassay Image Figure 5. Boronate Affinity Image Figure 6. Others Image Figure 7. Global POC HbA1C Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global POC HbA1C Testing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital and Clinics Image Figure 10. Diagnostic Laboratories Image Figure 11. Others Image Figure 12. Global POC HbA1C Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global POC HbA1C Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global POC HbA1C Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global POC HbA1C Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global POC HbA1C Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global POC HbA1C Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global POC HbA1C Testing Revenue Market Share by Type (2021-2032) Figure 20. Global POC HbA1C Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global POC HbA1C Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global POC HbA1C Testing Revenue Market Share by Application (2021-2032) Figure 23. North America POC HbA1C Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America POC HbA1C Testing Revenue Share by Type (2021-2032) Figure 25. North America POC HbA1C Testing Revenue Share by Application (2021-2032) Figure 26. North America POC HbA1C Testing Revenue Share by Country (2021-2032) Figure 27. United States POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe POC HbA1C Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe POC HbA1C Testing Revenue Share by Type (2021-2032) Figure 32. Europe POC HbA1C Testing Revenue Share by Application (2021-2032) Figure 33. Europe POC HbA1C Testing Revenue Share by Country (2021-2032) Figure 34. Germany POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China POC HbA1C Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China POC HbA1C Testing Revenue Share by Type (2021-2032) Figure 44. China POC HbA1C Testing Revenue Share by Application (2021-2032) Figure 45. Asia POC HbA1C Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia POC HbA1C Testing Revenue Share by Type (2021-2032) Figure 47. Asia POC HbA1C Testing Revenue Share by Application (2021-2032) Figure 48. Asia POC HbA1C Testing Revenue Share by Region (2021-2032) Figure 49. Japan POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA POC HbA1C Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA POC HbA1C Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA POC HbA1C Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA POC HbA1C Testing Revenue Share by Country (2021-2032) Figure 59. Brazil POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt POC HbA1C Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Immunoassay
  • Boronate Affinity
  • Others
Applications
  • Hospital and Clinics
  • Diagnostic Laboratories
  • Others
Companies covered
  • Abbott
  • Siemens
  • Roche
  • Bio-Rad
  • GREEN CROSS MEDIS
  • Trinity Biotech
  • HUMAN Diagnostics
  • Sinocare (PTS Diagnostics)
  • Erba Diagnostics
  • EKF Diagnostics
  • OSANG Healthcare
  • SD Biosensor

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 POC HbA1C Testing Market by Type
  3. 1.2.1 Global POC HbA1C Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immunoassay
  5. 1.2.3 Boronate Affinity
  6. 1.2.4 Others
  7. 1.3 POC HbA1C Testing Market by Application
  8. 1.3.1 Global POC HbA1C Testing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital and Clinics
  10. 1.3.3 Diagnostic Laboratories
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 POC HbA1C Testing Market Dynamics
  1. 2.1 POC HbA1C Testing Industry Trends
  2. 2.2 POC HbA1C Testing Industry Drivers
  3. 2.3 POC HbA1C Testing Industry Opportunities and Challenges
  4. 2.4 POC HbA1C Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global POC HbA1C Testing Market Perspective (2021-2032)
  2. 3.2 Global POC HbA1C Testing Growth Trends by Region
  3. 3.2.1 Global POC HbA1C Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global POC HbA1C Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global POC HbA1C Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global POC HbA1C Testing Revenue by Players
  2. 4.1.1 Global POC HbA1C Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global POC HbA1C Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global POC HbA1C Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global POC HbA1C Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global POC HbA1C Testing Key Players Headquarters & Area Served
  7. 4.4 Global POC HbA1C Testing Players, Product Type & Application
  8. 4.5 Global POC HbA1C Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global POC HbA1C Testing Market CR5 and HHI
  11. 4.6.3 2025 POC HbA1C Testing Tier 1, Tier 2, and Tier 3
5 POC HbA1C Testing Market Size by Type
  1. 5.1 Global POC HbA1C Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global POC HbA1C Testing Revenue by Type (2021-2032)
  3. 5.3 Global POC HbA1C Testing Revenue Market Share by Type (2021-2032)
6 POC HbA1C Testing Market Size by Application
  1. 6.1 Global POC HbA1C Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global POC HbA1C Testing Revenue by Application (2021-2032)
  3. 6.3 Global POC HbA1C Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott POC HbA1C Testing Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Siemens
  8. 7.2.1 Siemens Company Information
  9. 7.2.2 Siemens Business Overview
  10. 7.2.3 Siemens POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Siemens POC HbA1C Testing Product Portfolio
  12. 7.2.5 Siemens Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche POC HbA1C Testing Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Bio-Rad
  20. 7.4.1 Bio-Rad Company Information
  21. 7.4.2 Bio-Rad Business Overview
  22. 7.4.3 Bio-Rad POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bio-Rad POC HbA1C Testing Product Portfolio
  24. 7.4.5 Bio-Rad Recent Developments
  25. 7.5 GREEN CROSS MEDIS
  26. 7.5.1 GREEN CROSS MEDIS Company Information
  27. 7.5.2 GREEN CROSS MEDIS Business Overview
  28. 7.5.3 GREEN CROSS MEDIS POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GREEN CROSS MEDIS POC HbA1C Testing Product Portfolio
  30. 7.5.5 GREEN CROSS MEDIS Recent Developments
  31. 7.6 Trinity Biotech
  32. 7.6.1 Trinity Biotech Company Information
  33. 7.6.2 Trinity Biotech Business Overview
  34. 7.6.3 Trinity Biotech POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Trinity Biotech POC HbA1C Testing Product Portfolio
  36. 7.6.5 Trinity Biotech Recent Developments
  37. 7.7 HUMAN Diagnostics
  38. 7.7.1 HUMAN Diagnostics Company Information
  39. 7.7.2 HUMAN Diagnostics Business Overview
  40. 7.7.3 HUMAN Diagnostics POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 HUMAN Diagnostics POC HbA1C Testing Product Portfolio
  42. 7.7.5 HUMAN Diagnostics Recent Developments
  43. 7.8 Sinocare (PTS Diagnostics)
  44. 7.8.1 Sinocare (PTS Diagnostics) Company Information
  45. 7.8.2 Sinocare (PTS Diagnostics) Business Overview
  46. 7.8.3 Sinocare (PTS Diagnostics) POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sinocare (PTS Diagnostics) POC HbA1C Testing Product Portfolio
  48. 7.8.5 Sinocare (PTS Diagnostics) Recent Developments
  49. 7.9 Erba Diagnostics
  50. 7.9.1 Erba Diagnostics Company Information
  51. 7.9.2 Erba Diagnostics Business Overview
  52. 7.9.3 Erba Diagnostics POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Erba Diagnostics POC HbA1C Testing Product Portfolio
  54. 7.9.5 Erba Diagnostics Recent Developments
  55. 7.10 EKF Diagnostics
  56. 7.10.1 EKF Diagnostics Company Information
  57. 7.10.2 EKF Diagnostics Business Overview
  58. 7.10.3 EKF Diagnostics POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 EKF Diagnostics POC HbA1C Testing Product Portfolio
  60. 7.10.5 EKF Diagnostics Recent Developments
  61. 7.11 OSANG Healthcare
  62. 7.11.1 OSANG Healthcare Company Information
  63. 7.11.2 OSANG Healthcare Business Overview
  64. 7.11.3 OSANG Healthcare POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 OSANG Healthcare POC HbA1C Testing Product Portfolio
  66. 7.11.5 OSANG Healthcare Recent Developments
  67. 7.12 SD Biosensor
  68. 7.12.1 SD Biosensor Company Information
  69. 7.12.2 SD Biosensor Business Overview
  70. 7.12.3 SD Biosensor POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SD Biosensor POC HbA1C Testing Product Portfolio
  72. 7.12.5 SD Biosensor Recent Developments
8 North America
  1. 8.1 North America POC HbA1C Testing Revenue (2021-2032)
  2. 8.2 North America POC HbA1C Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America POC HbA1C Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America POC HbA1C Testing Revenue by Type (2027-2032)
  5. 8.3 North America POC HbA1C Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America POC HbA1C Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America POC HbA1C Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America POC HbA1C Testing Revenue by Application (2027-2032)
  9. 8.5 North America POC HbA1C Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America POC HbA1C Testing Revenue by Country
  11. 8.6.1 North America POC HbA1C Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America POC HbA1C Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America POC HbA1C Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe POC HbA1C Testing Revenue (2021-2032)
  2. 9.2 Europe POC HbA1C Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe POC HbA1C Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe POC HbA1C Testing Revenue by Type (2027-2032)
  5. 9.3 Europe POC HbA1C Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe POC HbA1C Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe POC HbA1C Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe POC HbA1C Testing Revenue by Application (2027-2032)
  9. 9.5 Europe POC HbA1C Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe POC HbA1C Testing Revenue by Country
  11. 9.6.1 Europe POC HbA1C Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe POC HbA1C Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe POC HbA1C Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China POC HbA1C Testing Revenue (2021-2032)
  2. 10.2 China POC HbA1C Testing Revenue by Type (2021-2032)
  3. 10.2.1 China POC HbA1C Testing Revenue by Type (2021-2026)
  4. 10.2.2 China POC HbA1C Testing Revenue by Type (2027-2032)
  5. 10.3 China POC HbA1C Testing Revenue Share by Type (2021-2032)
  6. 10.4 China POC HbA1C Testing Revenue by Application (2021-2032)
  7. 10.4.1 China POC HbA1C Testing Revenue by Application (2021-2026)
  8. 10.4.2 China POC HbA1C Testing Revenue by Application (2027-2032)
  9. 10.5 China POC HbA1C Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia POC HbA1C Testing Revenue (2021-2032)
  2. 11.2 Asia POC HbA1C Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia POC HbA1C Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia POC HbA1C Testing Revenue by Type (2027-2032)
  5. 11.3 Asia POC HbA1C Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia POC HbA1C Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia POC HbA1C Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia POC HbA1C Testing Revenue by Application (2027-2032)
  9. 11.5 Asia POC HbA1C Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia POC HbA1C Testing Revenue by Country
  11. 11.6.1 Asia POC HbA1C Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia POC HbA1C Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia POC HbA1C Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA POC HbA1C Testing Revenue (2021-2032)
  2. 12.2 SAMEA POC HbA1C Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA POC HbA1C Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA POC HbA1C Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA POC HbA1C Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA POC HbA1C Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA POC HbA1C Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA POC HbA1C Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA POC HbA1C Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA POC HbA1C Testing Revenue by Country
  11. 12.6.1 SAMEA POC HbA1C Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA POC HbA1C Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA POC HbA1C Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst